Matches in SemOpenAlex for { <https://semopenalex.org/work/W4252901174> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W4252901174 endingPage "704" @default.
- W4252901174 startingPage "698" @default.
- W4252901174 abstract "The inhibitors of protein prenylation have been proposed for chemotherapy of tumors. Lovastatin, a 3-hydroxy-3-methylglutaryl-Coenzyme A (HMG-CoA) reductase inhibitor, displays proapoptotic activity in tumor cells blocking the synthesis of isoprenoids compounds. To test whether HMG-CoA reductase inhibition can induce apoptosis in proliferating thyroid cells, we studied the effects of lovastatin in normal and neoplastic thyroid cells and in primary cultures from normal human thyroids. In an immortalized human thyroid cell line (TAD-2) and in neoplastic cells, lovastatin induced cell rounding within 24 h of treatment. After 48 h the cells were detached from the plate and underwent apoptosis, as evidenced by DNA fragmentation. Morphological changes and apoptosis did not occur in serum-starved quiescent TAD-2 cells or in primary cultures of normal thyrocytes. Mevalonate, the product of the HMG-CoA reductase enzymatic activity, and the protein synthesis inhibitor cycloheximide completely blocked the effects of lovastatin in a dose-dependent fashion. The geranylgeranyl transferase GGTI-298 inhibitor mimicked the effects of lovastatin on cell morphology and induced cell death, whereas the farnesyl transferase inhibitor FTI-277 was less effective to induce both cell rounding and apoptosis. Resistance to lovastatin-induced apoptosis by expression of the viral serpine CrmA and by the peptide inhibitor of caspases, Z-DEVD-fmk, demonstrated the involvement of CrmA-sensitive, caspase-3-like proteases. Inhibition of endogenous p53 activity did not affect the sensitivity of thyroid cells to lovastatin, demonstrating that this type of apoptosis is p53 independent. We conclude that lovastatin is a potent inducer of apoptosis in proliferating thyroid cells through inhibition of protein prenylation. This type of apoptosis requires protein synthesis, is CrmA sensitive and caspase-3-like protease dependent, and is independent from p53." @default.
- W4252901174 created "2022-05-12" @default.
- W4252901174 creator A5002036724 @default.
- W4252901174 date "1999-02-01" @default.
- W4252901174 modified "2023-09-29" @default.
- W4252901174 title "Prenyltransferase Inhibitors Induce Apoptosis in Proliferating Thyroid Cells through a p53-Independent, CrmA-Sensitive, and Caspase-3-Like Protease- Dependent Mechanism" @default.
- W4252901174 doi "https://doi.org/10.1210/en.140.2.698" @default.
- W4252901174 hasPublicationYear "1999" @default.
- W4252901174 type Work @default.
- W4252901174 citedByCount "7" @default.
- W4252901174 crossrefType "journal-article" @default.
- W4252901174 hasAuthorship W4252901174A5002036724 @default.
- W4252901174 hasBestOaLocation W42529011741 @default.
- W4252901174 hasConcept C104950815 @default.
- W4252901174 hasConcept C126322002 @default.
- W4252901174 hasConcept C134018914 @default.
- W4252901174 hasConcept C134651460 @default.
- W4252901174 hasConcept C181199279 @default.
- W4252901174 hasConcept C190283241 @default.
- W4252901174 hasConcept C2777827897 @default.
- W4252901174 hasConcept C2778163477 @default.
- W4252901174 hasConcept C2778396349 @default.
- W4252901174 hasConcept C2780940807 @default.
- W4252901174 hasConcept C31573885 @default.
- W4252901174 hasConcept C502942594 @default.
- W4252901174 hasConcept C54355233 @default.
- W4252901174 hasConcept C55493867 @default.
- W4252901174 hasConcept C57790582 @default.
- W4252901174 hasConcept C71924100 @default.
- W4252901174 hasConcept C81885089 @default.
- W4252901174 hasConcept C86803240 @default.
- W4252901174 hasConcept C98424977 @default.
- W4252901174 hasConceptScore W4252901174C104950815 @default.
- W4252901174 hasConceptScore W4252901174C126322002 @default.
- W4252901174 hasConceptScore W4252901174C134018914 @default.
- W4252901174 hasConceptScore W4252901174C134651460 @default.
- W4252901174 hasConceptScore W4252901174C181199279 @default.
- W4252901174 hasConceptScore W4252901174C190283241 @default.
- W4252901174 hasConceptScore W4252901174C2777827897 @default.
- W4252901174 hasConceptScore W4252901174C2778163477 @default.
- W4252901174 hasConceptScore W4252901174C2778396349 @default.
- W4252901174 hasConceptScore W4252901174C2780940807 @default.
- W4252901174 hasConceptScore W4252901174C31573885 @default.
- W4252901174 hasConceptScore W4252901174C502942594 @default.
- W4252901174 hasConceptScore W4252901174C54355233 @default.
- W4252901174 hasConceptScore W4252901174C55493867 @default.
- W4252901174 hasConceptScore W4252901174C57790582 @default.
- W4252901174 hasConceptScore W4252901174C71924100 @default.
- W4252901174 hasConceptScore W4252901174C81885089 @default.
- W4252901174 hasConceptScore W4252901174C86803240 @default.
- W4252901174 hasConceptScore W4252901174C98424977 @default.
- W4252901174 hasIssue "2" @default.
- W4252901174 hasLocation W42529011741 @default.
- W4252901174 hasOpenAccess W4252901174 @default.
- W4252901174 hasPrimaryLocation W42529011741 @default.
- W4252901174 hasRelatedWork W1966834268 @default.
- W4252901174 hasRelatedWork W1968876285 @default.
- W4252901174 hasRelatedWork W2009516407 @default.
- W4252901174 hasRelatedWork W2022458862 @default.
- W4252901174 hasRelatedWork W2053279347 @default.
- W4252901174 hasRelatedWork W2078309101 @default.
- W4252901174 hasRelatedWork W2129359920 @default.
- W4252901174 hasRelatedWork W2163504312 @default.
- W4252901174 hasRelatedWork W2166236611 @default.
- W4252901174 hasRelatedWork W2168843442 @default.
- W4252901174 hasVolume "140" @default.
- W4252901174 isParatext "false" @default.
- W4252901174 isRetracted "false" @default.
- W4252901174 workType "article" @default.